Status:
ACTIVE_NOT_RECRUITING
TAP Block With Lidocaine and Ropivacaine 0.2% (0.4 ml/kg/Side) for Pain and Opioid Reduction After Hysterectomy
Lead Sponsor:
Matild Keresztes
Conditions:
Postoperative Pain Following Hysterectomy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this study is to evaluate whether the Transversus Abdominis Plane (TAP) block can effectively reduce postoperative pain and opioid consumption in patients undergoing elective hysterectomy....
Detailed Description
Hysterectomy is a common gynecological surgical procedure involving the removal of the uterus. The procedure may be total or subtotal, and is frequently associated with moderate to severe postoperativ...
Eligibility Criteria
Inclusion
- Elective surgery
- Subumbilical incision (median, Phannenstil)
- Total or subtotal hysterectomy
- Age over 18 years
Exclusion
- Patient refusal
- Infection at the puncture site
- Chronic pain
- Chronic use of analgesics
- Contraindications to NSAIDs, local anesthetics, or opioids (e.g., tramadol: antidepressants, epileptic disorders)
- Severe hepatic disease
- Renal insufficiency (Creatinine Clearance ≤ 30 ml/min)
- Coagulopathy (Platelet count ≤ 75,000, INR ≥ 1.4)
Key Trial Info
Start Date :
January 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT07139691
Start Date
January 12 2024
End Date
December 31 2026
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
County Emergency Clinical Hospital of Targu Mureș
Târgu Mureş, Mureș County, Romania, 540136